Makoto Daimon
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
-
- Regulation of Appetite and Obesity
Papers in
-
- Porphyrin Metabolism and Disorders 15
- Metabolism, Diabetes, and Cancer 11
-
- Pituitary Gland Disorders and Treatments 14
- Hormonal Regulation and Hypertension 14
- Diabetes Treatment and Management 12
- Diabetes, Cardiovascular Risks, and Lipoproteins 11
- Co-authors
- Takeo Kato (89 shared papers)Makoto Tominaga (40 shared papers)Toshihide Oizumi (41 shared papers)Wataru Kameda (32 shared papers)Hiroshi Ohnuma (31 shared papers)Hiroshi Yamaguchi (23 shared papers)Masahiko Igarashi (25 shared papers)Toru Kawanami (22 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (13 papers)Diabetes Research and Clinical Practice (8 papers)Metabolism (8 papers)Peptides (7 papers)PLoS ONE (6 papers)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Makoto Daimon
210 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 130
- Endocrinology, Diabetes and Metabolism 921
- Endocrine and Autonomic Systems 192
- Nephrology 177
- Ophthalmology 199
- Neurology 164
Countries citing papers authored by Makoto Daimon
This map shows the geographic impact of Makoto Daimon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Daimon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Daimon more than expected).
Fields of papers citing papers by Makoto Daimon
This network shows the impact of papers produced by Makoto Daimon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Daimon. The network helps show where Makoto Daimon may publish in the future.
Co-authors
The 25 scholars most cited alongside Makoto Daimon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 215 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 296 | |
| 2 | 2008 | 142 | |
| 3 | 1990 | 132 | |
| 4 | 2008 | 115 | |
| 5 | 2007 | 93 | |
| 6 | 2004 | 91 | |
| 7 | 2008 | 86 | |
| 8 | 2006 | 78 | |
| 9 | 2016 | 77 | |
| 10 | 2016 | 74 | |
| 11 | 2003 | 65 | |
| 12 | 1993 | 63 | |
| 13 | 1988 | 63 | |
| 14 | 2001 | 63 | |
| 15 | 2006 | 59 | |
| 16 | 2010 | 58 | |
| 17 | 2007 | 58 | |
| 18 | 2004 | 56 | |
| 19 | 2021 | 55 | |
| 20 | 2007 | 54 |
About Makoto Daimon
Makoto Daimon is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery, Physiology and Epidemiology, having authored 215 papers that have together received 4.5k indexed citations. Recurring topics across this work include Porphyrin Metabolism and Disorders (15 papers), Pituitary Gland Disorders and Treatments (14 papers), Pancreatic function and diabetes (14 papers), Hormonal Regulation and Hypertension (14 papers), Stress Responses and Cortisol (12 papers), Diabetes Treatment and Management (12 papers), Metabolism, Diabetes, and Cancer (11 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (921 citations), Endocrine and Autonomic Systems (192 citations), Nephrology (177 citations), Ophthalmology (199 citations) and Neurology (164 citations). Makoto Daimon has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Takeo Kato, Makoto Tominaga, Toshihide Oizumi, Wataru Kameda, Hiroshi Ohnuma, Hiroshi Yamaguchi, Masahiko Igarashi, Toru Kawanami, Takamasa Kayama and Akihiko Hirata. Their work appears in journals such as Biochemical and Biophysical Research Communications, Diabetes Research and Clinical Practice, Metabolism, Peptides and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.